Skip to the page

Data / Form D filings / Aion Therapeutic Inc.

Aion Therapeutic Inc.: Form D filings

Aion Therapeutic Inc., a company in Vancouver, British Columbia, Canada, filed 6 Form D notices with the SEC between 2011 and 2024. The latest, on February 2, 2024, reports $5.8 million sold of a $5.8 million offering to 7 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
700 West Georgia Street, Suite 2200, Vancouver, British Columbia, Canada, V7Y 1
Phone
(604) 558-4300
Industry
Other
Entity type
Corporation
Incorporated in
British Columbia, Canada
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1521250

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Feb 2, 2024New notice$5,793,125$5,793,1257Dec 15, 2023sec.gov
Jan 27, 2012Amendment$1,168,750$25,000$1,143,7501May 2, 2011sec.gov
Nov 21, 2011New notice$227,292$34,216$193,0761Nov 16, 2011sec.gov
Nov 4, 2011New notice$241,737$10,082$231,6551Oct 24, 2011sec.gov
Sep 1, 2011New notice$9,168$9,1681Aug 31, 2011sec.gov
May 25, 2011New notice$1,168,750$25,000$1,143,7501May 2, 2011sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Larry HorwitzDirector
Graham SimmondsExecutive Officer
Anthony, Dr. HallDirector
Sara Lee IrwinDirector
Paul CrathDirector
Rakesh MalhotraExecutive Officer

Every Form D from the week of Jan 29, 2024 · All recent Other filings

Read from SEC EDGAR. Amount sold is what Aion Therapeutic Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.